---
title: "Dow 30 Earnings: DowDuPont Fourth Quarter Fiscal 2017"
description: dow 30, fourth-quarter earnings, DowDuPont, sales of $20.1 billion, GAAP loss per share of $0.52, restructuring and goodwill impairment charge of $3.1 billion
image: https://investor.valueline.com/hubfs/social-suggested-images/iStock-184958661-4.jpg
---

[![The Value Line Blog](https://investor.valueline.com/hubfs/VL%20Blog%20Images/vl_blog_header.png)](https://investor.valueline.com/blog)

[Stock Highlights](https://investor.valueline.com/blog/topic/stock-highlights)

# Dow 30 Earnings: DowDuPont Fourth Quarter Fiscal 2017

 February 1, 2018

Diversified chemicals manufacturer and Dow-30 component **DowDuPont** ([DWDP ](https://research.valueline.com/research#sec=company&sym=DWDP)– [Free DowDuPont Stock Report](https://research.valueline.com/api/report?documentID=2185-VL_20180105_VLIS_DWDP_25784_01-68LI8MGVJ0L16TOPHIJA1BCLJ8&symbol=DWDP)) has reported earnings for the December quarter. The conglomerate posted sales of $20.1 billion, benefiting from healthy underlying demand for many of its products. Adjusted earnings per share came in at $0.83, but the company reported a GAAP loss per share of $0.52. DowDuPont posted a loss from continuing operations of $2.87 billion, due to a restructuring and goodwill impairment charge of $3.1 billion. Wall Street was not happy with the news, sending the stock trading lower this morning.

The company experienced solid top-line performance across its operating segments and geographies. The Agriculture segment benefited from modest volume and currency improvements, though this was partly offset by local price declines. The Performance Materials & Coatings operation experienced a healthy increase in pricing and moderate volume growth. Meanwhile, the Industrial Intermediates & Infrastructure business posted impressive sales gains in all geographic regions. Elsewhere, the Packaging & Specialty Plastics line benefited from healthy consumer-led demand across key end-markets. The Electronics & Imaging operation capitalized on robust demand for mobile phones and other consumer electronics. Moreover, increased semiconductor content in end-use applications also provided support, though this was partly offset by a decline in sales of photovoltaics. In addition, greater demand for bioactives and microbial control solutions, along with continued growth in probiotics and pharmaceuticals, benefited the top line at the Nutrition & Biosciences operation. Finally, the Safety & Construction business experienced solid demand across construction, medical packaging, and industrial markets.

Looking forward, robust fundamentals augur well for future performance here. Leading indicators in developed economies suggest broad-based growth going forward. U.S. tax reform will likely act as a catalyst for domestic capital investments, and an emerging middle class in developing economies ought to support sustainable growth. We have increased our top-line estimate for full-year 2018, and now anticipate sales of $85 billion. We expect strong bottom-line improvement going forward. That said, we have reduced our bottom-line call for the current year by $0.70, to $3.00, in light of the share deficit generated in the recent period.

— Michael Napoli

At the time of this article’s writing, the author did not have positions in any of the companies mentioned.

[![Register now for our free One Stock to Buy webinar](https://no-cache.hubspot.com/cta/default/2532383/5a80130b-f0ce-4bd8-acbd-f077f2232ec5.png)](https://cta-redirect.hubspot.com/cta/redirect/2532383/5a80130b-f0ce-4bd8-acbd-f077f2232ec5)

### Popular Posts

Search

Search Blog

### Topics

- [Investing 101 (2)](https://investor.valueline.com/blog/topic/investing-101)
- [Market Commentary (37)](https://investor.valueline.com/blog/topic/market-commentary)
- [Stock Highlights (390)](https://investor.valueline.com/blog/topic/stock-highlights)
- [Stock Market Today (2071)](https://investor.valueline.com/blog/topic/stock-market-today)

 Copyright 2026 Value Line, Inc. All Rights Reserved. Factual material is obtained from sources believed to be reliable and is provided without warranties of any kind. VALUE LINE IS NOT RESPONSIBLE FOR ANY ERRORS OR OMISSIONS HEREIN OR ANY DAMAGES OR LOSSES ARISING FROM ANY USE OF THE INFORMATION CONTAINED HEREIN. This blog is strictly for subscriber's own, non-commercial, internal use. No part of it may be reproduced, stored or transmitted in any printed, electronic or other form, or used for generating or marketing any printed or electronic publication, service or product. Officers, directors, or employees of Value Line, Inc. and its affiliates and subsidiaries, and EULAV Asset Management, may own stocks that are featured in this email. Nothing herein should be construed as an offer to buy or sell securities or to give individual investment advice. Value Line, the Value Line logo, The Most Trusted Name in Investment Research, “Smart research. Smarter investing.”, The Value Line Investment Survey, Timeliness, and Safety are trademarks or registered trademarks of Value Line, Inc. and/or its affiliates in the United States and other countries.